IMM 1.64% 30.0¢ immutep limited

bad news for onty - stimuvax fails p3 trial, page-11

  1. 488 Posts.
    lightbulb Created with Sketch. 11
    Thanks arou11.

    A good read that sells the differences between CVAC, Stimuvax and Provenge

    Guess that Prima Management are letting Nomura do the talking for now.

    Would be good if they notified the ASX that the report is available.


    LC
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.